The NEU-1 inhibition by oseltamivir phosphate or its downregulation can impair the proliferation, apoptosis and epithelial-mesenchymal transition of breast cancer cells, and then, it can change the sialic acid level [40]. This evidence concerns the gene NEU1 and breast carcinoma.